NO20063186L - Inhibitorer av cyklinavhengige kinaser, preparater og anvendelser derav - Google Patents

Inhibitorer av cyklinavhengige kinaser, preparater og anvendelser derav

Info

Publication number
NO20063186L
NO20063186L NO20063186A NO20063186A NO20063186L NO 20063186 L NO20063186 L NO 20063186L NO 20063186 A NO20063186 A NO 20063186A NO 20063186 A NO20063186 A NO 20063186A NO 20063186 L NO20063186 L NO 20063186L
Authority
NO
Norway
Prior art keywords
inhibitors
cyclin
dependent kinases
preparations
applications
Prior art date
Application number
NO20063186A
Other languages
English (en)
Inventor
Nicholas Bockovich
Arthur Kluge
Krishna K Murthi
Siya Ram
Jianxing Huang
Chris Oalmann
Zhongguo Wang
Original Assignee
Gpc Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gpc Biotech Inc filed Critical Gpc Biotech Inc
Publication of NO20063186L publication Critical patent/NO20063186L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår nye inhibitorer av syklinavhengige kinaser (cdk) i følge formel I, hvori substituentene er som definert i kravene, og nærmere bestemt, men ikke utelukkende, som inhibitorer av cdk/syklinkomplekser. Som beskrevet heri kan inhibitorene ifølge foreliggende oppfinnelse hemme cellesyklusmaskineriet og vil følgelig være anvendbare for modulering av cellesyklusprogresjonen og til syvende og sist kontrollere cellevekst og differensiering. Slike forbindelser vil være anvendelige for behandling av individer med forstyrrelser forbundet med overdreven celleproliferasjon.
NO20063186A 2003-12-23 2006-07-10 Inhibitorer av cyklinavhengige kinaser, preparater og anvendelser derav NO20063186L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53187203P 2003-12-23 2003-12-23
US56013804P 2004-04-06 2004-04-06
US61648004P 2004-10-06 2004-10-06
PCT/US2004/043492 WO2005063765A1 (en) 2003-12-23 2004-12-21 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

Publications (1)

Publication Number Publication Date
NO20063186L true NO20063186L (no) 2006-09-20

Family

ID=34743691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063186A NO20063186L (no) 2003-12-23 2006-07-10 Inhibitorer av cyklinavhengige kinaser, preparater og anvendelser derav

Country Status (13)

Country Link
US (1) US8097619B2 (no)
EP (1) EP1709051A1 (no)
JP (1) JP4791975B2 (no)
KR (1) KR101155883B1 (no)
AU (1) AU2004309415B2 (no)
BR (1) BRPI0418095A (no)
CA (1) CA2551640C (no)
EA (1) EA013117B1 (no)
HK (1) HK1101399A1 (no)
IL (1) IL176543A0 (no)
MX (1) MXPA06007399A (no)
NO (1) NO20063186L (no)
WO (1) WO2005063765A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2584493A1 (en) * 2004-06-18 2006-01-05 Gpc Biotech, Inc. Kinase inhibitors for treating cancers
EP2019101A1 (en) 2007-07-26 2009-01-28 GPC Biotech AG Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
US8822447B2 (en) 2010-04-22 2014-09-02 Janssen Pharmaceutica Nv Indazole compounds useful as ketohexokinase inhibitors
BRPI1107312B1 (pt) 2011-11-25 2021-09-08 Universidade Federal De Santa Catarina Composto de acil-hidrazona
EP3548488A1 (en) 2016-11-30 2019-10-09 Oncotyrol Center for Personalized Cancer Medicine GmbH 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211732A (en) 1965-10-12 Pyrazolob:x-d]pyrlil/hdines
CH398626A (de) 1960-05-11 1966-03-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
JPS60130521A (ja) 1983-12-19 1985-07-12 Morishita Seiyaku Kk 抗癌剤
US4678499A (en) 1985-03-11 1987-07-07 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
JPS6299361A (ja) 1985-10-25 1987-05-08 Morishita Seiyaku Kk インデノ〔１，２−ｃ〕ピラゾ−ル誘導体
TW444018B (en) 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US5593997A (en) 1995-05-23 1997-01-14 Pfizer Inc. 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
US5866702A (en) 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
CN1297442A (zh) 1998-04-21 2001-05-30 杜邦药品公司 用作抗癌剂和抗增殖剂的5－氨基茚并[1,2－c]吡唑－4－酮类化合物
US6531477B1 (en) 1998-10-13 2003-03-11 Dupont Pharmaceuticals Company 6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
US6559152B2 (en) 1998-10-13 2003-05-06 Dupont Pharmaceuticals Company 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
US6291504B1 (en) 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
JP2004524277A (ja) 2000-10-20 2004-08-12 ブリストル−マイヤーズ スクイブ ファーマ カンパニー アシルセミカルバジド及びサイクリン依存性キナーゼ（ｃｄｋ）阻害剤としてのその使用
US6491971B2 (en) 2000-11-15 2002-12-10 G.T. Equipment Technologies, Inc Release coating system for crucibles
US6706718B2 (en) 2000-12-01 2004-03-16 Bristol-Myers Squibb Company 3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses
CA2439263C (en) 2001-03-02 2012-10-23 Frank Becker Three hybrid assay system
US7605175B2 (en) * 2001-03-02 2009-10-20 Gpc Biotech Ag Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
EP1404670A4 (en) 2001-07-06 2004-11-24 Bristol Myers Squibb Pharma Co SEMICARBAZIDES AND THEIR USE
US20040248905A1 (en) 2001-07-10 2004-12-09 Markwalder Jay A 6-Substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
PL369742A1 (en) * 2001-10-15 2005-05-02 Gpc Biotech Inc. Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
US6753329B2 (en) 2001-12-03 2004-06-22 Gpc Biotech Inc. Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

Also Published As

Publication number Publication date
US8097619B2 (en) 2012-01-17
HK1101399A1 (en) 2007-10-18
KR20060130624A (ko) 2006-12-19
AU2004309415A1 (en) 2005-07-14
CA2551640A1 (en) 2005-07-14
US20090209530A1 (en) 2009-08-20
AU2004309415B2 (en) 2010-08-26
BRPI0418095A (pt) 2007-04-17
JP2007516296A (ja) 2007-06-21
WO2005063765A1 (en) 2005-07-14
JP4791975B2 (ja) 2011-10-12
EA200601216A1 (ru) 2006-12-29
KR101155883B1 (ko) 2012-06-20
MXPA06007399A (es) 2007-01-26
CA2551640C (en) 2012-09-11
EP1709051A1 (en) 2006-10-11
EA013117B1 (ru) 2010-02-26
IL176543A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
MX2022001940A (es) Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2.
GEP20053660B (en) Novel Tyrosine Kinase Inhibitors
NO20062357L (no) Indolinderivater og anvendelse av dem ved behandling av sykdomstilstander som cancer
MXPA04004166A (es) Aminopirimidinas y piridinas.
UA95934C2 (ru) Производные пиридиазинона для лечения опухолей
AU2003205712A1 (en) Phenylalanine derivatives as herbicides
ATE525067T1 (de) Amino-substituierte (e)-2,6-dialkoxystyryl 4- substituierte benzylsulfone zur behandlung von proliferierenden erkrankungen
MY135050A (en) Organic compounds
GEP20063805B (en) Alkyne-Arylnaphthyridin-4-one as Phosphodiesterase-4 Inhibitors
PT1608647E (pt) Derivados de 5-feniltiazole e sua utilização como inibidores da quinase p13
NO20061194L (no) Mitotiske kinesininbibitorer
HK1065033A1 (en) Thiazole compounds useful as inhibitors or proteinkinases
TW200618800A (en) Heterocyclic compounds
NZ503828A (en) Aminothiazole inhibitors of cyclin dependent kinases
IS2416B (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
MY149960A (en) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
TW200630374A (en) Thiazolyldihydroindazoles
NO20063186L (no) Inhibitorer av cyklinavhengige kinaser, preparater og anvendelser derav
NO20082511L (no) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
WO2006130613A3 (en) Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
MX2008002104A (es) Derivados de 1-acildihidropirazol.
TNSN08020A1 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
WO2003033499A3 (en) Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
WO2004002477A8 (de) 2-(phenyl)-2h-pyrazol-3-carbonsäure-n-4-(thioxo-heterocyclyl)-phenyl-amid derivate und entsprechende imino-heterocyclyl derivate sowie verwandte verbindungen als inhibitoren der koagulationsfaktoren xa und/oder viia zur behandlung bon thrombosen
MX2021009426A (es) Derivados de indazolil-isoxazol para el tratamiento de enfermedades tales como cancer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application